Search

everythinglearnresearchcommunity

for

Search:↓

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Combining SADBE with other treatments can help hair regrowth in alopecia areata patients.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Baricitinib may not always prevent relapse in alopecia areata.

Biotin supplementation during isotretinoin treatment for acne may help maintain skin hydration and improve hair growth.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

The new wound dressing speeds up healing of infected wounds safely and effectively.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Certain substances can protect against ear damage from some antibiotics in zebrafish.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Aminoguanidine increases VEGF in stored hair micrografts, potentially improving their viability after transplant.

OBEME effectively enhances wound healing and could be a promising carrier for skin treatments.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

A dog in Germany was successfully treated for a rare bacterial infection without spreading it to humans.

Niosomes can effectively deliver cetirizine topically for treating alopecia.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.